Iclaprim

CAS No.

192314-93-5

MDL No.

MFCD09837803

C₁₉H₂₂N₄O₃

354.40

InChI Key

HWJPWWYTGBZDEG-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4-diamine is an aminopyrimidine in which a hydrogen of the methyl group in 5-methylpyrimidine-2,4-diamine is replaced by a 2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl group. It belongs to chromenes and cyclopropanes.

CAS No.	192314-93-5
Product Name	Iclaprim

Associated Conditions

skin disease·ventilator-associated pneumonia·bacterial disease·infection

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Documentation

Iclaprim

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Associated Conditions

Related Articles

Activity of iclaprim against Legionella pneumophila.

Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.

Investigational treatments for postoperative surgical site infections.

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

Documentation